PURPOSE: Prophylactic mesh placement has been proposed to reduce the high occurrence of parastomal hernia (PSH) after stoma formation. METHODS: This is an observational study comparing two cohorts of patients: a mesh prophylaxis group (who received mesh prevention since introduction at our Institution) and a no mesh prophylaxis group (retrospectively selected from our historical series). Same exclusion criteria were applied for both groups. The study was conducted at a tertiary referral center for colorectal surgery. 43 patients were operated with mesh prophylaxis between May 2015 and may 2019. 45 patients underwent end-colostomy formation without prophylaxis between April 2011 and April 2015. The primary outcome measure was PSH development at 12-month follow up. RESULTS: Demographic variables and risk factors for PSH were comparable between the two groups. There was no difference between the two cohorts in terms of operative time and main early postoperative outcomes. 37 patients completed the 12-month follow up in each group. PSH occurrence after 12-months was 11% in the mesh prophylaxis group and 54% in the no mesh prophylaxis group (p < 0.0001). There were no differences in long-term complications. 5% of patients who received mesh prophylaxis underwent emergency surgery for bowel occlusion at 7 and 10 months after surgery, with partial or complete mesh removal. At multivariate analysis, mesh prophylaxis was a protective factor for PSH development at 12 months (p < 0.0001). CONCLUSIONS: Prophylactic intraperitoneal mesh placement appears to be effective in preventing PSH.
PURPOSE: Prophylactic mesh placement has been proposed to reduce the high occurrence of parastomal hernia (PSH) after stoma formation. METHODS: This is an observational study comparing two cohorts of patients: a mesh prophylaxis group (who received mesh prevention since introduction at our Institution) and a no mesh prophylaxis group (retrospectively selected from our historical series). Same exclusion criteria were applied for both groups. The study was conducted at a tertiary referral center for colorectal surgery. 43 patients were operated with mesh prophylaxis between May 2015 and may 2019. 45 patients underwent end-colostomy formation without prophylaxis between April 2011 and April 2015. The primary outcome measure was PSH development at 12-month follow up. RESULTS: Demographic variables and risk factors for PSH were comparable between the two groups. There was no difference between the two cohorts in terms of operative time and main early postoperative outcomes. 37 patients completed the 12-month follow up in each group. PSH occurrence after 12-months was 11% in the mesh prophylaxis group and 54% in the no mesh prophylaxis group (p < 0.0001). There were no differences in long-term complications. 5% of patients who received mesh prophylaxis underwent emergency surgery for bowel occlusion at 7 and 10 months after surgery, with partial or complete mesh removal. At multivariate analysis, mesh prophylaxis was a protective factor for PSH development at 12 months (p < 0.0001). CONCLUSIONS: Prophylactic intraperitoneal mesh placement appears to be effective in preventing PSH.
Authors: S A Antoniou; F Agresta; J M Garcia Alamino; D Berger; F Berrevoet; H-T Brandsma; K Bury; J Conze; D Cuccurullo; U A Dietz; R H Fortelny; C Frei-Lanter; B Hansson; F Helgstrand; A Hotouras; A Jänes; L F Kroese; J R Lambrecht; I Kyle-Leinhase; M López-Cano; L Maggiori; V Mandalà; M Miserez; A Montgomery; S Morales-Conde; M Prudhomme; T Rautio; N Smart; M Śmietański; M Szczepkowski; C Stabilini; F E Muysoms Journal: Hernia Date: 2017-11-13 Impact factor: 4.739
Authors: M López-Cano; R Lozoya-Trujillo; S Quiroga; J L Sánchez; F Vallribera; M Martí; L M Jiménez; M Armengol-Carrasco; E Espín Journal: Hernia Date: 2012-07-11 Impact factor: 4.739
Authors: Sven M van Dijk; Lucas Timmermans; Eva B Deerenberg; Bas Lamme; Gert-Jan Kleinrensink; Johannes Jeekel; Johan F Lange Journal: World J Surg Date: 2015-10 Impact factor: 3.352